What regulatory guidelines apply to 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7)?

The compound, 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7), is subject to various regulatory guidelines such as GHS classification, REACH regulations, and FDA/EPA requirements. It should be handled in accordance with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous characteristics like flammability, reactivity, and toxicity. REACH regulations require registration and reporting for substances with a threshold of 1 ton per year. Additionally, the FDA and EPA may have specific regulations for its use in pharmaceuticals and environmental release, respectively.